Molecular Interaction Atlas (MIA) |
|
Indication(s) of Pizotyline |
Disease Entry |
ICD 11 |
Status |
REF |
Headache |
8A80-8A84
|
Approved |
[2] |
|
|
Pizotyline Interacts with 1 DTT Molecule(s)
DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
5-HT receptor (5HTR)
|
TT85JO3
|
NOUNIPROTAC
|
Modulator
|
[4] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
Pizotyline Interacts with 1 DME Molecule(s)
DME Name |
DME ID |
UniProt ID |
Mode of Action |
REF |
UDP-glucuronosyltransferase 2B10 (UGT2B10)
|
DEI8NGH
|
UDB10_HUMAN
|
Metabolism
|
[5] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
Pizotyline Interacts with 1 DOT Molecule(s)
DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
Potassium voltage-gated channel subfamily H member 2 (KCNH2)
|
OTZX881H
|
KCNH2_HUMAN
|
Decreases Activity
|
[6] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
Indication(s) of Terameprocol |
Disease Entry |
ICD 11 |
Status |
REF |
Solid tumour/cancer |
2A00-2F9Z
|
Phase 2 |
[3] |
|
|
Terameprocol Interacts with 1 DTT Molecule(s)
DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
Transcription factor Sp1 (SP1)
|
TTZEP6S
|
SP1_HUMAN
|
Modulator
|
[3] |
------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|